James E. Graham

7.2k total citations
113 papers, 3.3k citations indexed

About

James E. Graham is a scholar working on Epidemiology, General Health Professions and Emergency Medicine. According to data from OpenAlex, James E. Graham has authored 113 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 27 papers in General Health Professions and 21 papers in Emergency Medicine. Recurrent topics in James E. Graham's work include Geriatric Care and Nursing Homes (21 papers), Emergency and Acute Care Studies (20 papers) and Frailty in Older Adults (16 papers). James E. Graham is often cited by papers focused on Geriatric Care and Nursing Homes (21 papers), Emergency and Acute Care Studies (20 papers) and Frailty in Older Adults (16 papers). James E. Graham collaborates with scholars based in United States, United Kingdom and Germany. James E. Graham's co-authors include Kenneth J. Ottenbacher, Glenn V. Ostir, Amol Karmarkar, Steven R. Fisher, Carl V. Granger, Kyriakos S. Markides, Anne Deutsch, Steve Fisher, Soham Al Snih and Timothy Reistetter and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

James E. Graham

112 papers receiving 3.2k citations

Peers

Countries citing papers authored by James E. Graham

Since Specialization

Citations

This map shows the geographic impact of James E. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Graham more than expected).

Fields of papers citing papers by James E. Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Graham. The network helps show where James E. Graham may publish in the future.

Co-authorship network of co-authors of James E. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Graham. A scholar is included among the top collaborators of James E. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Graham. James E. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA 2025 ·PharmacoEconomics ·Hiral Shah, (unknown), (unknown), James E. Graham, (unknown), (unknown), Elise Kuylen, (unknown), Frederik Verelst, (unknown)	0
2	Home-based EEG Neurofeedback for the Treatment of Chronic Pain: A Randomized Controlled Clinical Trial 2024 ·Journal of Pain ·David A. Rice, (unknown), (unknown), (unknown), Irene Zeng, (unknown), (unknown), Usman Rashid, James E. Graham, M. T. Kluger	1
3	Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States 2024 ·Infectious Diseases and Therapy ·(unknown), Elizabeth M. La, Frederik Verelst, Sara Poston, James E. Graham, (unknown), Desmond Curran	14
4	Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States 2024 ·Human Vaccines & Immunotherapeutics ·Elizabeth M. La, James E. Graham, David Singer, (unknown), Sara Poston, Desmond Curran, (unknown), Frederik Verelst	4
5	Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States 2024 ·PharmacoEconomics ·Hiral Shah, (unknown), (unknown), James E. Graham, Katherine A. Hicks, Justin Carrico, (unknown), (unknown), (unknown), (unknown), Elise Kuylen, (unknown), (unknown)	1
6	EPH45 Assessing the Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in the United States (US) 2023 ·Value in Health ·(unknown), Elizabeth M. La, Frederik Verelst, Desmond Curran, Sara Poston, (unknown), James E. Graham	1
7	Child Voice in Parenting Coordination: Toward a Model of Inclusion 2020 ·Family Court Review ·(unknown), James E. Graham, (unknown)	1
8	PIH36 ECONOMIC BURDEN OF UNINTENDED PREGNANCY IN THE UNITED STATES 2019 ·Value in Health ·Anna Filonenko, Amy Law, (unknown), (unknown), James E. Graham	1
9	Is Profit Status of Inpatient Rehabilitation Facilities Independently Associated With 30-Day Unplanned Hospital Readmission for Medicare Beneficiaries? 2017 ·Archives of Physical Medicine and Rehabilitation ·Chih‐Ying Li, Amol Karmarkar, Yu–Li Lin, Yong‐Fang Kuo, Kenneth J. Ottenbacher, James E. Graham	6
10	Motor and Cognitive Functional Status Are Associated with 30-day Unplanned Rehospitalization Following Post-Acute Care in Medicare Fee-for-Service Beneficiaries 2016 ·Journal of General Internal Medicine ·Addie Middleton, James E. Graham, Yu‐Li Lin, James S. Goodwin, Janet Prvu Bettger, Anne Deutsch, Kenneth J. Ottenbacher	25
11	Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria 2016 ·PharmacoEconomics ·James E. Graham, Doreen McBride, Donald E. Stull, (unknown), (unknown), Maria‐Magdalena Balp, (unknown), Ion Agirrezabal, Torsten Zuberbier, Alan Brennan	25
12	Hospital Readmission Following Discharge From Inpatient Rehabilitation for Older Adults With Debility 2015 ·Physical Therapy ·(unknown), Amol Karmarkar, James E. Graham, Alai Tan, Mukaila Raji, Carl V. Granger, Kenneth J. Ottenbacher	24
13	Adapting Literature-Based Remission Rates for Chronic Spontaneous/Idiopathic Urticaria to The Needs of A Health Economic Model: A Kaplan-Meier Approach 2015 ·Value in Health ·G Partha, (unknown), S. Bhattacharyya, (unknown), (unknown), James E. Graham, M.M. Balp, Alexander Marsland	1
14	Factors Associated with Provision of Wheelchairs in Older Adults 2012 ·Assistive Technology ·Amol Karmarkar, Brad E. Dicianno, James E. Graham, Rosemarie Cooper, Annmarie Kelleher, Rory A. Cooper	25
15	Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States 2011 ·American Journal of Obstetrics and Gynecology ·Thomas N. Taylor, Raymond Farkouh, James E. Graham, Antje Colligs, (unknown), R. Lynen, Sean D. Candrilli	11
16	Obesity and Disability: Relation Among Older Adults Living in Latin America and the Caribbean 2010 ·American Journal of Epidemiology ·Soham Al Snih, James E. Graham, Yong‐Fang Kuo, James S. Goodwin, Kyriakos S. Markides, Kenneth J. Ottenbacher	56
17	Anaesthesia Non-Technical Skills: can anaesthetists be trained to reliably use this behavioural marker system in 1 day? 2010 ·British Journal of Anaesthesia ·James E. Graham, Graham Hocking, Erin D. Giles	47
18	The Uniform Data System for Medical Rehabilitation 2009 ·American Journal of Physical Medicine & Rehabilitation ·Carl V. Granger, Samuel J. Markello, James E. Graham, Anne Deutsch, Kenneth J. Ottenbacher	72
19	Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis 2009 ·Applied Health Economics and Health Policy ·Stephanie Earnshaw, James E. Graham, MerriKay Oleen-Burkey, Jane Castelli‐Haley, K. B. Johnson	33
20	Sex Differences in Mortality among Older Frail Mexican Americans 2009 ·Journal of Women s Health ·Ivonne-Marie Bergés, James E. Graham, Glenn V. Ostir, Kyriakos S. Markides, Kenneth J. Ottenbacher	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact